Johnson & Johnson has temporarily suspended its trials of the COVID-19 vaccine on a sick participant. A pause in vaccine trials involving 60,000 patients makes it possible to check whether the disease is related to the drug. J & J said the disease is "an expected part of any clinical trial." cnews.com / news / covid-base...